Literature DB >> 28626801

B lymphocytes and cancer: a love-hate relationship.

Grace J Yuen1, Ezana Demissie1, Shiv Pillai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28626801      PMCID： PMC5472356          DOI： 10.1016/j.trecan.2016.10.010

Source DB:  PubMed          Journal:  Trends Cancer        ISSN： 2405-8025


× No keyword cloud information.
  112 in total

1.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.

Authors:  T Okazaki; A Maeda; H Nishimura; T Kurosaki; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

Authors:  Purevdorj B Olkhanud; Dolgor Baatar; Monica Bodogai; Fran Hakim; Ronald Gress; Robin L Anderson; Jie Deng; Mai Xu; Susanne Briest; Arya Biragyn
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

3.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

Review 4.  Tumor antigens.

Authors:  G Klein
Journal:  Annu Rev Microbiol       Date:  1966       Impact factor: 15.500

Review 5.  B cells and autoimmunity.

Authors:  Shiv Pillai; Hamid Mattoo; Annaiah Cariappa
Journal:  Curr Opin Immunol       Date:  2011-11-24       Impact factor: 7.486

6.  The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model.

Authors:  Tamar Tadmor; Yu Zhang; Hyun-Mi Cho; Eckhard R Podack; Joseph D Rosenblatt
Journal:  Cancer Immunol Immunother       Date:  2011-01-21       Impact factor: 6.968

Review 7.  Immune infiltration in human tumors: a prognostic factor that should not be ignored.

Authors:  F Pagès; J Galon; M-C Dieu-Nosjean; E Tartour; C Sautès-Fridman; W-H Fridman
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

8.  Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α.

Authors:  Katarzyna Wejksza; Catalina Lee-Chang; Monica Bodogai; Jessica Bonzo; Frank J Gonzalez; Elin Lehrmann; Kevin Becker; Arya Biragyn
Journal:  J Immunol       Date:  2013-02-13       Impact factor: 5.422

9.  Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers.

Authors:  Erica M Pimenta; Betsy J Barnes
Journal:  Cancers (Basel)       Date:  2014-04-23       Impact factor: 6.639

10.  The immune landscape of human tumors: Implications for cancer immunotherapy.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Helen K Angell; Jérôme Galon
Journal:  Oncoimmunology       Date:  2014-01-03       Impact factor: 8.110
View more
  109 in total

Review 1.  B cells, plasma cells and antibody repertoires in the tumour microenvironment.

Authors:  George V Sharonov; Ekaterina O Serebrovskaya; Diana V Yuzhakova; Olga V Britanova; Dmitriy M Chudakov
Journal:  Nat Rev Immunol       Date:  2020-01-27       Impact factor: 53.106

2.  Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice.

Authors:  Daniel Triner; Samantha N Devenport; Sadeesh K Ramakrishnan; Xiaoya Ma; Ryan A Frieler; Joel K Greenson; Naohiro Inohara; Gabriel Nunez; Justin A Colacino; Richard M Mortensen; Yatrik M Shah
Journal:  Gastroenterology       Date:  2018-12-11       Impact factor: 22.682

Review 3.  Complex interplay between tumor microenvironment and cancer therapy.

Authors:  Minhong Shen; Yibin Kang
Journal:  Front Med       Date:  2018-08-10       Impact factor: 4.592

4.  A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity.

Authors:  Diana Rasoulouniriana; Nadine Santana-Magal; Amit Gutwillig; Leen Farhat-Younis; Yariv Wine; Corey Saperia; Lior Tal; Haim Gutman; Alexander Tsivian; Ronen Brenner; Eiman Abu Bandora; Nathan E Reticker-Flynn; Peleg Rider; Yaron Carmi
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

5.  B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer.

Authors:  Bhalchandra Mirlekar; Daniel Michaud; Samuel J Lee; Nancy P Kren; Cameron Harris; Kevin Greene; Emily C Goldman; Gaorav P Gupta; Ryan C Fields; William G Hawkins; David G DeNardo; Naim U Rashid; Jen Jen Yeh; Autumn J McRee; Benjamin G Vincent; Dario A A Vignali; Yuliya Pylayeva-Gupta
Journal:  Cancer Immunol Res       Date:  2020-02-05       Impact factor: 11.151

6.  Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes.

Authors:  Won Jin Ho; Mark Yarchoan; Soren Charmsaz; Rebecca M Munday; Ludmila Danilova; Marcelo B Sztein; Elana J Fertig; Elizabeth M Jaffee
Journal:  JCI Insight       Date:  2020-01-30

7.  Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.

Authors:  Louis T Curtis; Susanne Sebens; Hermann B Frieboes
Journal:  Cancer Immunol Immunother       Date:  2020-11-12       Impact factor: 6.968

Review 8.  [Prognostic significance of immune cell infiltrates in tumor pathology].

Authors:  D-C Wagner; W Roth
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

9.  Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma.

Authors:  Xiaoru Sun; Lu Wang; Hongkai Li; Chuandi Jin; Yuanyuan Yu; Lei Hou; Xinhui Liu; Yifan Yu; Ran Yan; Fuzhong Xue
Journal:  Aging (Albany NY)       Date:  2021-06-16       Impact factor: 5.682

Review 10.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.